Collectively, our findings offer an early illustration of how an anti-RhoB antibody may be useful for the study and treatment of autoimmune disorders driven by the production of pathogenic autoantibodies, including RA, SLE, myasthenia gravis and type 1 diabetes. Here, RHOB is linked to rheumatoid arthritis.